Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

CARVYKTI is a B-cell maturation antigen-targeted therapy for treating patients with multiple myeloma. Credit: Shidlovski/Shutterstock. Health Canada has issued a notice of compliance (NOC) for Johnson ...

HYMPAVZI is a once-weekly subcutaneous treatment option for individuals with severe haemophilia A or B. Credit: ...

TV personality Dr Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid ...

Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.